Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeSt for kids in juvenile idiopathic arthritis
NL-OMON26585Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in juvenile idiopathic arthritis (JIA) comparing Initial sulfasalazine strategy, Initial methotrexate plus prednisone bridging strategy and Initial etanercept plus methotrexate strategy (3 arms). Primary endpoints: Time to remission and Time to flare. Started Jun 2009; status: active, not recruiting.
02
Drugs
5-aminosalicylic acid + sulphasalazinemethotrexateprednisoneetanercept
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NL-OMON26585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26585.